The aim of the study was to investigate the prospective associations between CRP during pregnancy and in the early postpartum with adverse metabolic outcomes including body fat, insulin resistance and secretion at 1 year postpartum in women with GDM and to determine the extent to which potential relationships are independent of body weight or fat or fat-free mass. Here, CRP is linked to gestational diabetes.